Hepatic encephalopathy.
Fraser
C L
CL
Arieff
A I
AI
D000641:Ammonia / Q000097:blood / Q000378:metabolism; D000818:Animals; D001812:Blood-Brain Barrier; D001921:Brain / Q000378:metabolism; D003711:Demyelinating Diseases / Q000209:etiology; D005227:Fatty Acids / Q000097:blood; D005973:Glutamine / Q000134:cerebrospinal fluid; D006501:Hepatic Encephalopathy / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D006955:Hypernatremia / Q000139:chemically induced; D007010:Hyponatremia / Q000139:chemically induced; D007656:Ketoglutaric Acids / Q000134:cerebrospinal fluid; D007792:Lactulose / Q000009:adverse effects / Q000627:therapeutic use; D008715:Methionine / Q000097:blood; D009355:Neomycin / Q000009:adverse effects / Q000627:therapeutic use; D011149:Pons; D009435:Synaptic Transmission; D014364:Tryptophan / Q000097:blood
D005227:Fatty Acids; D007656:Ketoglutaric Acids; D005973:Glutamine; D007792:Lactulose; D000641:Ammonia; D014364:Tryptophan; D008715:Methionine; D009355:Neomycin